Sameer Bakhshi Selected Research

CAV protocol

4/2015

Intracranial atypical teratoid rhabdoid tumor: current management and a single institute experience of 15 patients from north India.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sameer Bakhshi Research Topics

Disease

71	Neoplasms (Cancer) 05/2022 - 03/2003
26	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 05/2004
21	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 11/2006
16	Retinoblastoma (Glioblastoma, Retinal) 06/2020 - 03/2010
14	Osteosarcoma (Osteogenic Sarcoma) 03/2022 - 12/2009
11	Infections 08/2022 - 02/2004
11	Leukemia 01/2022 - 11/2006
9	Hodgkin Disease (Hodgkin's Disease) 06/2022 - 01/2006
9	Sarcoma (Soft Tissue Sarcoma) 04/2022 - 10/2010
9	Necrosis 03/2022 - 08/2008
9	Neoplasm Metastasis (Metastasis) 02/2022 - 12/2010
9	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2020 - 03/2007
7	Ewing Sarcoma (Sarcoma, Ewing) 01/2022 - 10/2010
7	Primitive Neuroectodermal Tumors (PNET) 09/2017 - 04/2009
6	Vomiting 10/2022 - 02/2011
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2022 - 07/2020
6	Carcinoma (Carcinomatosis) 09/2021 - 10/2013
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2017 - 05/2010
5	Neuroblastoma 10/2021 - 10/2010
5	Febrile Neutropenia 10/2021 - 09/2009
5	Residual Neoplasm 01/2021 - 09/2012
5	Lymphoma (Lymphomas) 01/2019 - 01/2006
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2022 - 03/2014
4	Nausea 10/2022 - 02/2011
4	COVID-19 08/2022 - 11/2020
4	Wilms Tumor (Wilm's Tumor) 02/2022 - 06/2017
4	Mucormycosis 12/2021 - 01/2005
4	Fever (Fevers) 10/2021 - 09/2009
4	Mucositis 10/2018 - 03/2011
3	Adenoid Cystic Carcinoma (Cylindroma) 02/2022 - 12/2009
3	Hematologic Neoplasms (Hematological Malignancy) 12/2021 - 09/2017
3	Stomatitis 01/2020 - 01/2008
3	Carcinogenesis 04/2019 - 05/2004
3	Mycoses (Diseases, Fungus) 03/2015 - 06/2008
3	Thrombosis (Thrombus) 10/2014 - 08/2003
2	Reinfection 08/2022 - 01/2022
2	Tumor Lysis Syndrome 08/2022 - 05/2017
2	Hepatoblastoma 05/2022 - 06/2017
2	Pathologic Complete Response 01/2022 - 12/2008
2	Sepsis (Septicemia) 12/2021 - 08/2003
2	Uveal melanoma 05/2021 - 12/2019
2	Disease Progression 07/2020 - 09/2017
2	Melanoma (Melanoma, Malignant) 03/2020 - 01/2010
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2020 - 05/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2019 - 07/2019
2	Pneumonia (Pneumonitis) 04/2019 - 02/2004

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 03/2022 - 05/2014
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022 - 12/2009
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2010
8	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 03/2007
6	selinexorIBA 02/2022 - 07/2020
6	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 02/2004
6	Vincristine (Oncovin)FDA LinkGeneric 05/2017 - 11/2008
5	Cisplatin (Platino)FDA LinkGeneric 05/2022 - 02/2011
5	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 03/2013
4	Aprepitant (Emend)FDA Link 10/2022 - 06/2015
4	Messenger RNA (mRNA)IBA 01/2022 - 10/2011
4	Mitochondrial DNA (mtDNA)IBA 01/2021 - 01/2018
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 11/2006
4	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 01/2019
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2017 - 12/2010
3	AntigensIBA 12/2021 - 05/2004
3	Rituximab (Mabthera)FDA Link 01/2021 - 01/2018
3	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 05/2017
3	Cadherins (E-Cadherin)IBA 01/2020 - 10/2015
3	Immunoglobulin G (IgG)IBA 03/2015 - 03/2009
2	VaccinesIBA 08/2022 - 01/2022
2	pazopanib FDA Link 04/2022 - 01/2021
2	MicroRNAs (MicroRNA)IBA 02/2022 - 01/2017
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2022 - 05/2015
2	MicronutrientsIBA 01/2022 - 05/2015
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 05/2015
2	galactomannanIBA 12/2021 - 04/2013
2	Immune Checkpoint InhibitorsIBA 05/2021 - 01/2021
2	Fumigant 93 (D-D)IBA 01/2021 - 10/2019
2	CTLA-4 AntigenIBA 01/2021 - 06/2020
2	AntiemeticsIBA 10/2020 - 02/2011
2	Tyrosine Kinase InhibitorsIBA 06/2020 - 01/2020
2	IceIBA 01/2020 - 04/2015
2	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2020 - 11/2006
2	Hemoglobins (Hemoglobin)IBA 01/2020 - 01/2008
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 11/2015
2	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 01/2020
2	VimentinIBA 01/2020 - 03/2014
2	CateninsIBA 07/2019 - 07/2019
2	EnzymesIBA 07/2019 - 01/2017
2	Cathepsin BIBA 01/2019 - 12/2010
2	Cathepsin LIBA 01/2018 - 04/2015

Therapy/Procedure

77	Drug Therapy (Chemotherapy) 10/2022 - 02/2004
53	Therapeutics 06/2022 - 03/2003
18	Neoadjuvant Therapy 04/2021 - 12/2009
16	Radiotherapy 01/2022 - 03/2003
6	Induction Chemotherapy 10/2020 - 01/2008
3	Stem Cell Transplantation 07/2020 - 07/2012
3	Chemoradiotherapy 01/2016 - 04/2009
2	Ligation 10/2022 - 01/2019
2	Transplantation 10/2021 - 09/2017
2	Hematopoietic Stem Cell Transplantation 04/2019 - 04/2013
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2017 - 11/2006
2	Nephrectomy 06/2017 - 10/2014